JHIU
Janus Henderson Investors US Portfolio holdings
AUM
$122B
1-Year Return
18.25%
This Quarter Return
+4.99%
1 Year Return
+18.25%
3 Year Return
+41.87%
5 Year Return
–
10 Year Return
–
AUM
$109B
AUM Growth
+$1.51B
(+1.4%)
Cap. Flow
-$3.26B
Cap. Flow
% of AUM
-2.99%
Top 10 Holdings %
Top 10 Hldgs %
13.69%
Holding
1,139
New
85
Increased
453
Reduced
516
Closed
52
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$268M |
| 2 |
Microsoft
MSFT
|
$223M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
$215M |
| 4 |
Zimmer Biomet
ZBH
|
$214M |
| 5 |
Aon
AON
|
$173M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$447M |
| 2 |
Oracle
ORCL
|
$383M |
| 3 |
Teradata
TDC
|
$280M |
| 4 |
CELG
Celgene Corp
CELG
|
$277M |
| 5 |
Canadian Pacific Kansas City
CP
|
$274M |
Sector Composition
| 1 | Healthcare | 16.94% |
| 2 | Technology | 14.95% |
| 3 | Industrials | 12.42% |
| 4 | Financials | 11.64% |
| 5 | Consumer Discretionary | 10.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Marsh & McLennan
MMC
$100B
| $203M | 0.19% |
3,924,920
+146,100
| +4% | +$7.57M |
|
152
Fiserv
FI
$73.4B
| $203M | 0.19% |
6,733,316
+166,200
| +3% | +$5.01M |
|
153
Crown Holdings
CCK
$11B
| $202M | 0.19% |
4,063,351
-479,423
| -11% | -$23.9M |
|
154
EQT Corp
EQT
$32.2B
| $202M | 0.19% |
3,471,256
+429,491
| +14% | +$25M |
|
|
155
Oracle
ORCL
$654B
| $201M | 0.18% |
4,964,092
-9,460,419
| -66% | -$383M |
|
156
NextEra Energy, Inc.
NEE
$146B
| $198M | 0.18% |
7,742,524
+1,093,200
| +16% | +$28M |
|
157
Boston Scientific
BSX
$159B
| $198M | 0.18% |
15,527,722
-922,400
| -6% | -$11.8M |
|
158
Broadridge
BR
$29.4B
| $195M | 0.18% |
4,694,698
-101,729
| -2% | -$4.24M |
|
159
HEICO Class A
HEI.A
$35.1B
| $193M | 0.18% |
9,275,346
-402,131
| -4% | -$8.36M |
|
160
Blackbaud
BLKB
$3.23B
| $191M | 0.18% |
5,346,664
-207,353
| -4% | -$7.41M |
|
161
ON Semiconductor
ON
$20.1B
| $190M | 0.17% |
20,812,856
-1,835,157
| -8% | -$16.8M |
|
162
Jack Henry & Associates
JKHY
$11.8B
| $190M | 0.17% |
3,190,547
-167,064
| -5% | -$9.93M |
|
163
Becton Dickinson
BDX
$55.1B
| $188M | 0.17% |
1,631,073
+180,912
| +12% | +$20.9M |
|
164
IBM
IBM
$232B
| $188M | 0.17% |
1,084,403
-43,351
| -4% | -$7.51M |
|
165
Bristol-Myers Squibb
BMY
$96B
| $186M | 0.17% |
3,839,665
-3,328,125
| -46% | -$161M |
|
166
Gildan
GIL
$8.27B
| $185M | 0.17% |
6,273,290
+87,560
| +1% | +$2.58M |
|
167
Gartner
IT
$18.6B
| $184M | 0.17% |
2,613,226
+123,423
| +5% | +$8.7M |
|
168
Allstate
ALL
$53.1B
| $184M | 0.17% |
3,137,152
-456,300
| -13% | -$26.8M |
|
169
Charles Schwab
SCHW
$167B
| $183M | 0.17% |
6,812,085
-370,300
| -5% | -$9.97M |
|
170
Elevance Health
ELV
$70.6B
| $183M | 0.17% |
1,696,802
-51,000
| -3% | -$5.49M |
|
171
TransDigm Group
TDG
$71.6B
| $181M | 0.17% |
1,082,214
+85,354
| +9% | +$14.3M |
|
|
AGN
172
DELISTED
ALLERGAN INC
AGN
| $179M | 0.16% |
1,060,539
-429,820
| -29% | -$72.7M |
|
173
Henry Schein
HSIC
$8.42B
| $177M | 0.16% |
3,800,660
+27,609
| +0.7% | +$1.28M |
|
174
Tyson Foods
TSN
$20B
| $176M | 0.16% |
4,688,795
+1,174,600
| +33% | +$44.1M |
|
175
Cognizant
CTSH
$35.1B
| $176M | 0.16% |
3,598,600
+2,116,270
| +143% | +$104M |
|